[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-348952-105":59,"doc-detail-348952-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","an-integrated-analysis-of-men1-reveals-its-associations-with-clinical-outcomes-cellular-pathways-and-the-immune-microenvironment","An integrated analysis of MEN1 reveals its associations with clinical outcomes, cellular pathways, and the immune microenvironment","","The menin protein encoded by the Multiple Endocrine Neoplasia Type 1 (MEN1) gene is a key regulator of cellular processes in human cancers, yet a comprehensive view of its diagnostic, prognostic, and immunomodulatory roles across tumors remains incomplete. This study integrates multi-omics expression profiling and immunohistochemical data to link MEN1 upregulation with adverse survival, diagnostic performance, tumor mutation burden, immune checkpoint expression, infiltration patterns, and pathway activation. MEN1 is proposed as a biomarker and therapeutic target for immuno-oncology and precision medicine.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-integrated-analysis-of-men1-reveals-its-associations-with-clinical-outcomes-cellular-pathways-and-the-immune-microenvironment/348952/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-integrated-analysis-of-men1-reveals-its-associations-with-clinical-outcomes-cellular-pathways-and-the-immune-microenvironment/348952.png","ImageObject",300,407,{"name":92,"@type":93},"LangkahRina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What data and analyses were used to study MEN1?","Question",{"text":113,"@type":114},"MEN1 expression and relevance were evaluated using multi-omics databases together with immunohistochemical profiles from the Human Protein Atlas (HPA), supported by pathway analyses including GSEA and ssGSEA.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does higher MEN1 expression relate to clinical outcomes?",{"text":118,"@type":114},"Elevated MEN1 expression is associated with adverse survival outcomes across multiple malignancies, indicating prognostic relevance.",{"name":120,"@type":111,"acceptedAnswer":121},"What immune-related associations were found for MEN1?",{"text":122,"@type":114},"MEN1 expression correlates with immune checkpoint genes and patterns of immune cell infiltration, linking MEN1 to the tumor immune microenvironment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},348952,1790328910,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Li etal. World Journal of Surgical Oncology (2026) 24:349  \n[https://doi.org/10.1186/s12957-026-04460-x](https://doi.org/10.1186/s12957-026-04460-x)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nAn integrated analysis of MEN1 reveals its associations with clinical outcomes, cellular pathways, and the immune microenvironment  \nHao Li1, Xinyu Gong2, Yanwei Yao1, Ping Bi1, Qiang Li2*, Xiaoru Wang1* and Jian Peng3*  \nAbstract  \nThe menin protein, encoded by the Multiple Endocrine Neoplasia Type 1 (MEN1) gene, serves as a critical regulator of cellular processes in human cancers. While menin-targeted therapies are undergoing clinical investigation, a comprehensive pan-cancer analysis of MEN1's diagnostic, prognostic, and immunomodulatory roles remain lacking. Here, we systematically evaluated MEN1 expression patterns and clinical relevance using multi-omics databasesand immunohistochemical profiles from the Human Protein Atlas (HPA) . MEN1 exhibited ubiquitous expression in normal tissues but was frequently upregulated across multiple malignancies, correlating with adverse survival outcomes. Elevated MEN1 expression demonstrated strong diagnostic utility and positive associations with tumor mutation burden (TMB), suggesting complementary value in cancer detection. Immune landscape analysis revealed significant correlations between MEN1 expression and immune checkpoint genes, as well as immune cell infiltration patterns. Functional characterization implicated MEN1 in activating cell cycle progression, DNA damage response, and oncogenic signaling pathways, as validated through Gene Set Enrichment Analysis (GSEA) and single-sample Gene Set Enrichment Analysis (ssGSEA) . These findings position MEN1 as a promising prognostic biomarker and therapeutic target with implications for immuno-oncology and precision medicine.  \nKeywords MEN1, Pan-cancer, Prognosis, Immune microenvironment, Biomarker  \n*Correspondence: Qiang Li [lee.q@126.com](lee.q@126.com)[ ](lee.q@126.com)Xiaoru Wang [2790214801@qq.com](2790214801@qq.com)[ ](2790214801@qq.com)Jian Peng [1518572156@qq.com](1518572156@qq.com)  \n1Department of Critical Care Medicine, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China  \n2Department of Cardiothoracic Surgery, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China  \n3Anhui Institute of Pediatric Research, Anhui Provincial Children’s Hospital, Hefei, Anhui 230051, China  \nIntroduction  \nCancer, characterized by uncontrolled cellular proliferation and evasion of regulatory mechanisms, remains a leading cause of mortality worldwide [1]. Recent advances in oncology have introduced diverse therapeutic modalities, including surgical resection, cytotoxic chemotherapy, ionizing radiation, molecularly targeted agents, and immunotherapeutic strategies. Despite these innovations, the prognosis for patients with advanced malignancies remains suboptimal. High recurrence ratesand limited survival benefits persist across many tumor types [2, 3]. This clinical impasse underscores the urgent need for identifying novel prognostic biomarkers and therapeutic targets to improve patient outcomes.  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intende","cbCainpMyXOmm80i","https://ap.wps.com/l/cbCainpMyXOmm80i","pdf",9687621,16,"English","# Abstract\n## Methods and data sources\n## Key findings: clinical outcomes and diagnosis\n## Immune microenvironment associations\n## Functional pathway implications","[{\"question\":\"What data and analyses were used to study MEN1?\",\"answer\":\"MEN1 expression and relevance were evaluated using multi-omics databases together with immunohistochemical profiles from the Human Protein Atlas (HPA), supported by pathway analyses including GSEA and ssGSEA.\"},{\"question\":\"How does higher MEN1 expression relate to clinical outcomes?\",\"answer\":\"Elevated MEN1 expression is associated with adverse survival outcomes across multiple malignancies, indicating prognostic relevance.\"},{\"question\":\"What immune-related associations were found for MEN1?\",\"answer\":\"MEN1 expression correlates with immune checkpoint genes and patterns of immune cell infiltration, linking MEN1 to the tumor immune microenvironment.\"}]","An integrated analysis of MEN1 reveals its associations with clinical outcomes, cellular pathways, and the immune microenvironment | PDF",1790080780,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95589c1b56e51b4b00f87ac5c364063b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75ec2ba42c7438f3d20622c2ff595f98.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2c10b79fcce1a662fa977f4713df177.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/080d292276daef9254c8b4b847d1fce5.webp",980,1306]